Barclays Upgrades Fortrea Holdings to Overweight, Raises Price Target to $23
10/6/2026
Impact: 70
Healthcare
Barclays analyst Luke Sergott has upgraded Fortrea Holdings (NASDAQ: FTRE) from Equal-Weight to Overweight. The price target for the stock has been raised from $22 to $23.
AI summary, not financial advice
Share: